IFAR’s strategic plan outlines the future of research at Hebrew SeniorLife, and positions us to have an increasing influence on quality of life for seniors. As always, our goals for the future are driven by our commitment to focused research with real-world impact.
Our key initiatives include:
Translational research: We’re developing a clinical trials unit that will operate within IFAR to help us extend our research findings. We’re also partnering with Brandeis University’s Heller School for Social Policy and Management to develop a joint Center to Inform Health Care Policy and Practice in Aging. This collaborative effort will translate clinical research into policy and practice recommendations that improve the quality and reduce the cost of senior health care and promote healthy aging.
Geriomics: IFAR has one of the only scientific programs in the U.S. dedicated to studying the genetic mechanisms of diseases associated with old age. Working at the genetic level allows us to develop personalized treatments to prevent or cure many diseases and disabilities of old age. We’ll continue to build on our international reputation for research.
Professional Support: IFAR currently attracts top-tier researchers. To continue to ensure a pipeline of research talent, future initiatives include professional development to support pilot projects, sabbaticals so senior faculty can remain at the cutting edge of gerontological research and postdoctoral training and junior faculty positions.
Informatics: Our researchers need an environment where clinical studies are designed, managed, and assessed with rigorous and relevant statistical methods. They need fast, easy access to research data. We’re developing a high-performance computing and storage infrastructure to provide on-demand cloud-based services to all IFAR personnel.